Search This Blog

Friday, June 26, 2026

Euro regulators urge revoking Amgen’s EU marketing authorization for its vasculitis drug Tavneos.

 European medicines regulators recommend revoking Amgen’s EU marketing authorization for its vasculitis drug Tavneos.

https://finviz.com/stock?t=AMGN&p=d

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)